Drugs Made In America Acquisition II Corp. Ordinary Shares
DMIIStockNASDAQ
$10.08 ▲ +0.00%
12 juin 2026
D
Drugs Made In America Acquisition II Corp. Ordinary Shares
$10.08 ▲ +0.00%
12 juin 2026
DMIIStockNASDAQ

01 / À propos

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Arberion
Loading market data